Chinese Drug Developer Lynk Pharmaceuticals Secures Funding Of Usd50 Million
Chinese Drug Developer Lynk Pharmaceuticals Secures Funding Of Usd50 Million
08/27/21, 12:40 PM
Lynk Pharmaceuticals has raised USD50 million in its latest fundraiser, led by Lilly Asia Ventures, a unit of US pharmaceutical giant Eli Lilly.
Company Info
Company
Lynk Pharmaceuticals
Additional Info
The proceeds of the Series B financing round are earmarked for Phase I and II clinical trials of products in the Chinese drug developer’s pipeline and to help it strengthen cooperation with leading global firms, the Hangzhou-based startup said today.
